Dr. Marianna GrammatikaRegional Head of Risk Consulting at Allianz CommercialLatest in HomeSponsoredWhy Biocompatibility Plans Should Focus on Storytelling, Not Data DumpingApril 9, 2026Dassault Systèmes Buys Life Sciences AI Specialist ArisGlobalJuly 24, 2026NeuraNova Gets FDA OK for Bioimpedance Spectroscopy DeviceJuly 23, 2026FDA Approves Philips' New Pulse OximeterJuly 23, 2026Related StoriesHome4 Ways to Spark Gen Z Interest in ManufacturingHomeHow to Maximize Manufacturing Efficiency with Hybrid Product DevelopmentNewsBill Gerard Named President Arterex North AmericaSponsor ContentMusk Says Neuralink Will Begin ‘High-Volume’ Production of Brain Implants
